We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FL
1026
DELISTED
Foot Locker
FL
| $591K | 0.01% |
+14,879
| New | +$622K |
|
1027
Tootsie Roll Industries
TR
$2.97B
| $590K | 0.01% |
+14,358
| New | +$573K |
|
1028
Timken Company
TKR
$9.85B
| $588K | 0.01% |
7,200
+2,138
| +42% | +$173K |
|
1029
Novavax
NVAX
$1.23B
| $588K | 0.01% |
+84,800
| New | +$780K |
|
1030
Zions Bancorporation
ZION
$10.3B
| $586K | 0.01% |
19,579
+1,622
| +9% | +$74.2K |
|
1031
Peabody Energy
BTU
$2.63B
| $586K | 0.01% |
22,874
+14,058
| +159% | +$374K |
|
1032
Ingles Markets
IMKTA
$1.74B
| $586K | 0.01% |
+6,601
| New | +$612K |
|
1033
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
| $583K | 0.01% |
+7,271
| New | +$576K |
|
1034
Teekay Tankers
TNK
$2.74B
| $581K | 0.01% |
+13,542
| New | +$502K |
|
1035
CALL
HCA Healthcare
HCA
$88.2B
| $580K | 0.01% |
2,200
| – | – |
|
1036
Cooper Companies
COO
$14.5B
| $579K | 0.01% |
+6,204
| New | +$533K |
|
1037
Sportsman's Warehouse
SPWH
$45.7M
| $578K | 0.01% |
+68,190
| New | +$622K |
|
1038
Progressive
PGR
$123B
| $578K | 0.01% |
4,039
-19,838
| -83% | -$2.74M |
|
1039
Axsome Therapeutics
AXSM
$10.9B
| $575K | 0.01% |
+9,316
| New | +$612K |
|
|
CD
1040
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $574K | 0.01% |
+82,115
| New | +$629K |
|
1041
Graco
GGG
$13B
| $573K | 0.01% |
7,844
-17,334
| -69% | -$1.2M |
|
|
ITI
1042
DELISTED
Iteris, Inc.
ITI
| $572K | 0.01% |
121,930
| – | – |
|
1043
Illumina
ILMN
$31.1B
| $568K | 0.01% |
2,511
+1,305
| +108% | +$267K |
|
1044
BorgWarner
BWA
$13.2B
| $564K | 0.01% |
13,052
+4,896
| +60% | +$203K |
|
1045
Stryker
SYK
$129B
| $562K | 0.01% |
+1,967
| New | +$522K |
|
1046
PUT
Blue Owl Capital
OBDC
$5.41B
| $561K | 0.01% |
44,500
+17,500
| +65% | +$225K |
|
1047
Harrow
HROW
$1.43B
| $561K | 0.01% |
+26,513
| New | +$452K |
|
|
SCS
1048
DELISTED
Steelcase
SCS
| $561K | 0.01% |
+66,580
| New | +$511K |
|
1049
Liberty Global Class A
LBTYA
$3.74B
| $561K | 0.01% |
28,745
+3,561
| +14% | +$72.3K |
|
1050
Amdocs
DOX
$5.95B
| $559K | 0.01% |
+5,823
| New | +$539K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.